How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Donor-Derived West Nile Virus Infection in Kidney Transplant Recipients, France, 2025 – Volume 32, Number 2—February 2026 – Emerging Infectious Diseases journal

Early Release – Pulmonary Complications in Fatal Yellow Fever, Brazil, 2017–2019 – Volume 32, Number 2—February 2026 – Emerging Infectious Diseases journal

Early Release – Using Routine Surveillance Data to Assess Dengue Virus Transmission Risk in Travelers Returning to the United States – Volume 32, Number 2—February 2026 – Emerging Infectious Diseases journal

Early Release – Vesicular Disease Caused by Seneca Valley Virus in Pigs, England, 2022 – Volume 32, Number 2—February 2026 – Emerging Infectious Diseases journal

Early Release – Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom – Volume 32, Number 2—February 2026 – Emerging Infectious Diseases journal

Communicable disease threats report, 7 – 13 February 2026, week 7

Early Release – Correction: Vol. 32, No. 1 – Volume 32, Number 2—February 2026 – Emerging Infectious Diseases journal

Early Release – Avian Influenza A(H9N2) Virus Transmission across Chicken Production and Distribution Networks, Vietnam – Volume 32, Number 2—February 2026 – Emerging Infectious Diseases journal

Early Release – Multicenter Serologic Investigation of Influenza D Virus in Cats and Dogs, Europe, 2015–2024 – Volume 32, Number 2—February 2026 – Emerging Infectious Diseases journal

Early Release – Autochthonous Rat Lungworm Angiostrongylus cantonensis Infections in Accidental and Definitive Hosts, San Diego, California, USA – Volume 32, Number 2—February 2026 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us